These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4477250)

  • 1. A preliminary report on the action of imipramine and antiparkinsonian agents on the open field behaviour of rats.
    Kulkarni SK; Dandiya PC
    Jpn J Pharmacol; 1974 Oct; 24(5):809-10. PubMed ID: 4477250
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of amantadine and of some synthetic antiparkinsonian drugs on the behavioral response to L-DOPA in mice.
    Florio V; Longo VG
    Physiol Behav; 1971 Apr; 6(4):465-6. PubMed ID: 5148760
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
    Johnson AM; Vigouret JM; Loew DM
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R40. PubMed ID: 4276573
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of antidepressant agents on open field behaviour in rats.
    Kulkarni SK; Dandiya PC
    Psychopharmacologia; 1973 Dec; 33(4):333-8. PubMed ID: 4798172
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and antireserpine activity of peptides of L-dopa.
    Felix AM; Winter DP; Wang SS; Kulesha ID; Pool WR; Hane DL; Sheppard H
    J Med Chem; 1974 Apr; 17(4):422-6. PubMed ID: 4857423
    [No Abstract]   [Full Text] [Related]  

  • 6. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
    Puri SK; Reddy C; Lal H
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
    [No Abstract]   [Full Text] [Related]  

  • 7. On the mechanism of potentiation of amphetamine induced stereotype behaviour by imipramine.
    Kulkarni SK; Dandiya PC
    Psychopharmacologia; 1972; 27(4):367-72. PubMed ID: 4265208
    [No Abstract]   [Full Text] [Related]  

  • 8. Action of m-tyrosine in experimental models: evidence for possible antiparkinsonian activity.
    Ungerstedt U; Fuxe K; Goldstein M; Battista A; Ogawa M; Anagnoste B
    Eur J Pharmacol; 1973 Feb; 21(2):230-7. PubMed ID: 4633120
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats.
    Kulkarni SK; Dandiya PC
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):45-50. PubMed ID: 1233511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological basis for N-n-propylnorapomorphine induced stereotypic cage climbing and behavioral arousal in mice.
    Wilcox RE; Riffee WH; Smith RV
    Pharmacol Biochem Behav; 1979 Dec; 11(6):653-9. PubMed ID: 43980
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of amantadine and L-dopa on apomorphine- and d-amphetamine-induced stereotyped behaviour in rats.
    Cox B; Tha SJ
    Eur J Pharmacol; 1973 Oct; 24(1):96-100. PubMed ID: 4796449
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental evaluation of the possible neuroleptic activity of clomipramine.
    Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1978; 22(3):263-9. PubMed ID: 31334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antiparkinson drugs on the liguomandibular reflex in cats.
    Barnett A; Fiore JW
    Eur J Pharmacol; 1973 Feb; 21(2):178-82. PubMed ID: 4696100
    [No Abstract]   [Full Text] [Related]  

  • 15. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 16. Head-turning induced by electrical stimulation of the caudate nucleus and its antagonism by anti-parkinson drugs.
    Barnett A; Goldstein J
    J Pharmacol Exp Ther; 1975 Aug; 194(2):296-302. PubMed ID: 1171223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thymoleptics on behaviour associated with changes in brain dopamine. I. Potentiation of dopa-induced gnawing of mice.
    Molander L; Randrup A
    Psychopharmacologia; 1976 Feb; 45(3):261-5. PubMed ID: 943120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural and biochemical comparison of amphetamine derivatives, cocaine, benztropine and tricyclic anti-depressant drugs.
    Scheel-Krüger J
    Eur J Pharmacol; 1972 Apr; 18(1):63-73. PubMed ID: 5031275
    [No Abstract]   [Full Text] [Related]  

  • 20. Videotaping: the evaluation of stereotypic effects of antiparkinsonian agents.
    Wilcox RE; Riffee WH; Smith RV
    Pharmacol Biochem Behav; 1979 Jan; 10(1):161-4. PubMed ID: 571607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.